News
Stay up to date on topics that are important to Nurse Practitioners.
-
Hyperlipidemia treatments gaining popularity
Two newer FDA-approved treatments for hyperlipidemia are gaining popularity due to their effectiveness and dosing. A statin alternative,…
-
New Oral Medication to Treat Postpartum Depression Approved by FDA
Between 6.5% and 20% of new mothers develop postpartum depression (PPD), though many more may go undiagnosed. PPD…
-
First Vaccine for Pregnant Individuals to Prevent RSV in Infants Approved by FDA
On August 21, 2023, the U.S. FDA approved Abrysvo, a Respiratory Syncytial Virus vaccine, for pregnant individuals. The…
-
Three Pieces of National Legislation Aim to Protect Patients and Nurses
Three bills introduced to the U.S. Congress in 2023 have brought issues affecting nurses and patients to the…
-
Artificial Intelligence in Healthcare
Artificial intelligence. It’s the latest buzzword in countless professions, and healthcare is no exception. ChatGPT and other forms…
-
FDA Approves First Over-the-Counter Birth Control Pill in the U.S.
On July 13, 2023, the FDA approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy. Opill is…
-
New Drug to Prevent RSV in Infants and Toddlers Approved By FDA
U.S. Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory…
-
Recent AANP Letter to Congress Expresses Support for ICAN Act
The American Association of Nurse Practitioners (AANP) and other healthcare organizations recently sent a letter to the leaders…
-
First COVID-19 At-Home Test Receives Marketing Authorization from FDA
On June 6, the Cue COVID-19 Molecular Test received marketing authorization from the FDA. Intended to detect genetic…
-
Wildfire Smoke Increases Risk of Lung Disease, Inflammation, Other Health Risks
Unseasonable heat and drought contributed to an unprecedented outbreak of wildfires across eastern Canada in April and May.…
-
What the End of the COVID-19 Public Health Emergency Means for Healthcare Professionals
On May 11th, the national Public Health Emergency (PHE) for COVID-19, declared under Section 319 of the Public…
-
First Drug to Treat Agitation Symptoms Associated with Alzheimer’s-Related Dementia Approved by FDA
On May 11th, the FDA announced its supplemental approval of Rexulti (brexpiprazole) oral tablets for treatment of agitation…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
Beyond Prescriptions: 6 Tips for a Holistic FNP Approach to Psychopharmacology
-
How to Set Boundaries to Avoid NP Burnout
-
Using Technology to Combat Drug-Drug Interactions
-
Ten Key Tips for Balancing School, Work, and Life as an NP Student
-
Top 5 Lab Test Result Interpretation Mistakes (and How to Avoid Them)
-
Understanding Nurse Practitioner Board Exam Options and Benefits
-
Top Pitfalls in Interpreting Common Diagnostic Images and How to Avoid Them
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
-
Multistate Outbreak of Salmonella Linked to Cucumbers
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.